BF
MRTX

BOK Financial’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

BOK Financial’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$343K Buy
+1,999
New +$396K 0.01% 758

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BOK Financial's MRTX Position: Q1 2021 in Review

BOK Financial opened a new position in Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2021: 1,999 shares worth $343K. The stake represents 0.01% of the portfolio and ranks #758 among its holdings.

260 funds tracked by Wall St. Rank hold MRTX as of Q1 2021.

  • BOK Financial held 1,999 shares of Mirati Therapeutics, Inc. Common Stock worth $343K as of Q1 2021.
  • Mirati Therapeutics, Inc. Common Stock was a new BOK Financial position in Q1 2021.
  • Mirati Therapeutics, Inc. Common Stock made up 0.01% of BOK Financial's portfolio in Q1 2021, its #758 holding.
  • 260 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2021.

Based on BOK Financial's 13F filing for Q1 2021, filed 21 Apr 2021.